Rui Cheng

2.2k total citations
52 papers, 1.8k citations indexed

About

Rui Cheng is a scholar working on Molecular Biology, Ophthalmology and Cancer Research. According to data from OpenAlex, Rui Cheng has authored 52 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 18 papers in Ophthalmology and 8 papers in Cancer Research. Recurrent topics in Rui Cheng's work include Retinal Diseases and Treatments (14 papers), Peroxisome Proliferator-Activated Receptors (10 papers) and Angiogenesis and VEGF in Cancer (10 papers). Rui Cheng is often cited by papers focused on Retinal Diseases and Treatments (14 papers), Peroxisome Proliferator-Activated Receptors (10 papers) and Angiogenesis and VEGF in Cancer (10 papers). Rui Cheng collaborates with scholars based in United States, China and Brazil. Rui Cheng's co-authors include Jian‐xing Ma, Xuemin He, Lexi Ding, Yusuke Takahashi, Siribhinya Benyajati, Guoquan Gao, Yang Hu, Kelu Zhou, Jingming Li and Qiuping Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Diabetes.

In The Last Decade

Rui Cheng

51 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui Cheng United States 28 974 442 238 184 165 52 1.8k
Lalit P. Singh United States 23 1.1k 1.1× 415 0.9× 121 0.5× 107 0.6× 191 1.2× 42 1.7k
Guanfang Su China 26 925 0.9× 669 1.5× 223 0.9× 289 1.6× 93 0.6× 90 1.8k
Qinghua Qiu China 22 694 0.7× 686 1.6× 411 1.7× 208 1.1× 65 0.4× 71 1.6k
Mohammad Mairaj Siddiquei Saudi Arabia 25 491 0.5× 708 1.6× 248 1.0× 176 1.0× 65 0.4× 53 1.4k
Jie Tang China 26 1.3k 1.4× 219 0.5× 140 0.6× 795 4.3× 90 0.5× 120 2.2k
Yu-Chuen Huang Taiwan 20 529 0.5× 147 0.3× 119 0.5× 131 0.7× 67 0.4× 59 1.2k
Yukichi Okuda Japan 27 647 0.7× 242 0.5× 176 0.7× 153 0.8× 450 2.7× 85 2.1k
Masako Mitsumata Japan 29 925 0.9× 188 0.4× 185 0.8× 415 2.3× 228 1.4× 65 2.5k
Yosuke Inagaki Japan 23 846 0.9× 385 0.9× 104 0.4× 150 0.8× 248 1.5× 29 2.5k
Denise McDonald United Kingdom 17 379 0.4× 205 0.5× 141 0.6× 54 0.3× 555 3.4× 34 1.5k

Countries citing papers authored by Rui Cheng

Since Specialization
Citations

This map shows the geographic impact of Rui Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Cheng more than expected).

Fields of papers citing papers by Rui Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Cheng. The network helps show where Rui Cheng may publish in the future.

Co-authorship network of co-authors of Rui Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Cheng. A scholar is included among the top collaborators of Rui Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Cheng. Rui Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cui, Yi, Kelu Zhou, Rui Cheng, et al.. (2025). Sustained release of a novel non-fibrate PPARα agonist from microparticles for neuroprotection in murine models of age-related macular degeneration. Journal of Controlled Release. 380. 910–926. 1 indexed citations
2.
Liang, Wentao, Li Huang, Rui Cheng, et al.. (2023). A Method for Real-Time Assessment of Mitochondrial Respiration Using Murine Corneal Biopsy. Investigative Ophthalmology & Visual Science. 64(11). 33–33. 4 indexed citations
3.
Cheng, Rui, et al.. (2023). The effect of APN, hs-CRP and APN/hs-CRP in periodontitis with DAA. BMC Oral Health. 23(1). 85–85. 1 indexed citations
5.
Yang, Yanhui, Xuemin He, Rui Cheng, et al.. (2020). Diabetes‐induced upregulation of kallistatin levels exacerbates diabetic nephropathy via RAS activation. The FASEB Journal. 34(6). 8428–8441. 11 indexed citations
6.
Han, Liang, Rui Cheng, Jiaoyang Wang, et al.. (2020). Mogrol, an aglycone of mogrosides, attenuates ulcerative colitis by promoting AMPK activation. Phytomedicine. 81. 153427–153427. 47 indexed citations
7.
Liu, Qiuping, Xian Zhang, Rui Cheng, et al.. (2019). Salutary effect of fenofibrate on type 1 diabetic retinopathy via inhibiting oxidative stress–mediated Wnt/β-catenin pathway activation. Cell and Tissue Research. 376(2). 165–177. 36 indexed citations
8.
Shao, Yan, Jianglei Chen, Lijie Dong, et al.. (2019). A Protective Effect of PPARα in Endothelial Progenitor Cells Through Regulating Metabolism. Diabetes. 68(11). 2131–2142. 35 indexed citations
9.
Pearsall, Elizabeth, Rui Cheng, Satoshi Matsuzaki, et al.. (2019). Neuroprotective effects of PPARα in retinopathy of type 1 diabetes. PLoS ONE. 14(2). e0208399–e0208399. 35 indexed citations
10.
Zhou, Kai, et al.. (2018). Eupatilin ameliorates dextran sulphate sodium-induced colitis in mice partly through promoting AMPK activation. Phytomedicine. 46. 46–56. 36 indexed citations
11.
McBride, Jeffrey D., Xiaochen Liu, William L. Berry, et al.. (2017). Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19+ B lymphocytes in the peripheral blood. International Journal of Hematology. 105(6). 748–757. 6 indexed citations
12.
Liu, Qiuping, Fengjun Zhang, Xian Zhang, et al.. (2017). Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation. Molecular and Cellular Biochemistry. 445(1-2). 105–115. 77 indexed citations
13.
Pearsall, Elizabeth, Rui Cheng, Kelu Zhou, et al.. (2017). PPARα is essential for retinal lipid metabolism and neuronal survival. BMC Biology. 15(1). 113–113. 42 indexed citations
14.
Ding, Lexi, Rui Cheng, Yang Hu, et al.. (2014). Peroxisome Proliferator–Activated Receptor α Protects Capillary Pericytes in the Retina. American Journal Of Pathology. 184(10). 2709–2720. 74 indexed citations
15.
Moran, Elizabeth, Lexi Ding, Zhongxiao Wang, et al.. (2014). Protective and Antioxidant Effects of PPARα in the Ischemic Retina. Investigative Ophthalmology & Visual Science. 55(7). 4568–4568. 63 indexed citations
16.
Zhou, Kelu, Siribhinya Benyajati, Yun Le, et al.. (2014). Interruption of Wnt Signaling in Müller Cells Ameliorates Ischemia-Induced Retinal Neovascularization. PLoS ONE. 9(10). e108454–e108454. 25 indexed citations
17.
Hu, Yang, Ying Chen, Lexi Ding, et al.. (2013). THE PATHOGENIC ROLE OF DOWN-REGULATION OF PPAR-ΑLPHA EXPRESSION IN DIABETIC RETINOPATHY. Investigative Ophthalmology & Visual Science. 54(15). 1152–1152. 1 indexed citations
18.
Chen, Hui, Jianping Zhang, Hui Huang, et al.. (2013). Leptin Promotes Fetal Lung Maturity and Upregulates SP-A Expression in Pulmonary Alveoli Type-II Epithelial Cells Involving TTF-1 Activation. PLoS ONE. 8(7). e69297–e69297. 26 indexed citations
19.
Zhang, Yang, et al.. (2012). Dual Inhibition of Plasminogen Kringle 5 on Angiogenesis and Chemotaxis Suppresses Tumor Metastasis by Targeting HIF-1α Pathway. PLoS ONE. 7(12). e53152–e53152. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026